Adjuvant Durvalumab Plus Tremelimumab Yields DFS Advantage in Resected RCC Read More » November 6, 2025
Comprehensive Molecular Profiling of Renal Medullary Carcinoma Identifies TROP2 As a Promising Therapeutic Target Read More » November 6, 2025
First-in-human CAIN trial demonstrates feasibility of histotripsy for small renal tumours Read More » October 16, 2025
Software-based versus visual assessment of the minimal ablative margin in patients with liver tumors undergoing percutaneous thermal ablation (COVER-ALL): a randomized phase 2 trial Read More » March 17, 2025
New data find cryoablation “highly effective” in treatment of solitary renal cell carcinoma Read More » May 24, 2024
